As a new type of foreign trade service provider driven by both technology transformation and foreign trade business, HiSiaddi has established a "1+2+3+4=1" service system and can supply original products from multiple well-known brands for bisphenol A bis(diphenyl phosphate). As a technology R&D-oriented foreign trade service provider with over ten years of market experience, HiSiaddi has rich experience addressing product compliance issues relying on technological transformation cooperation with manufacturers. The following is a case handled by HiSiaddi regarding compliance issues of bisphenol A bis(diphenyl phosphate).
Please contact HiSiaddi customer service if you need more consultation on compliance issues of bisphenol A bis(diphenyl phosphate) products.
The purchaser is MED-POLY New Materials Co., Ltd., Switzerland, specialized in production of high-end medical-grade PC/ABS, new energy vehicle precision housings and industrial high-end electrical plastic modified materials, supplying medical consumables for Roche, automotive interiors for Volvo and electronic control enclosures for Siemens. Five mandatory regulatory requirements apply to raw material access: EU REACH registration, SVHC high-concern substance control, LFGB food contact compliance, IMDS automotive material declaration and GHS dangerous goods shipping compliance. The annual rigid demand for BDP stands at 325 tons, shipped in five full containers from domestic leading manufacturers of high-purity medical-grade BDP.
The client previously signed a supply contract for the first batch of 65 tons with a first-tier domestic BDP manufacturer. After production, filling and container loading were completed, four fatal compliance loopholes emerged intensively on the eve of shipment to the Port of Rotterdam due to newly implemented Swiss customs policies and internal compliance audits by the client. Forcible customs declaration would likely result in detention and full container return by EU customs, incurring detention, container storage and rework fines with estimated single-container losses exceeding EUR 28,000. The localization procurement project was nearly canceled, and the client planned to revert to purchasing high-priced original European and American BDP. Four major compliance problems (domestic manufacturers only provided basic quality inspection certificates without supporting cross-border compliance documents):
1. Incomplete REACH compliance: The manufacturer’s BDP only held early pre-registration certificates without formal EU REACH main registration. ECHA updated the SVHC list to 253 items in 2026, yet the manufacturer lacked the latest full-item SVHC test reports, preventing EU SCIP notifications. New Swiss regulations prohibit customs clearance of chemical additives without SCIP notifications.
2. Disqualified LFGB certification for medical materials: The client uses BDP for Class II medical consumable substrates, while the manufacturer only possessed national food testing certificates without third-party German LFGB migration test reports, failing incoming warehouse audits by downstream Roche.
3. Blank IMDS automotive material declaration data: Volvo’s mandatory IMDS database entry for automotive modified materials required the manufacturer to provide complete BDP chemical component lists, split CAS numbers of substances and hazardous substance content data sheets, which the manufacturer failed to supply, preventing the client from completing full-vehicle material filing.
4. Non-compliant shipping dangerous goods packaging & GHS standards: BDP is classified as Class 9 miscellaneous dangerous chemicals. The manufacturer’s packaging lacked UN dangerous goods packaging certificates, bilingual Chinese-English GHS compliant labels, and MSDS adopted outdated national standard formats inconsistent with IMDG international shipping rules, leading shipping companies to refuse booking for shipment.
The client coordinated rectification with the raw material factory for 18 days with no results. Production manufacturers only focused on physical and chemical product quality, lacked compliance specialists familiar with European and American regulations, and refused additional investment in testing and registration fees, with rectification cycles far exceeding the client’s delivery deadlines. The client’s R&D and compliance departments were unfamiliar with China’s chemical registration, testing and dangerous goods declaration processes, formally entrusting HiSiaddi, the foreign trade service provider, to fully coordinate full-chain compliance rectification with a 15-day deadline to complete all compliance documents and ensure smooth shipment.
Leveraging its European chemical compliance database, cooperative domestic CNAS/CMA laboratories and EU Only Representative (OR) resources, HiSiaddi closed all compliance loopholes item by item across four major modules:
1. Deploy cooperative EU OR (Only Representative) to conduct joint registration data sharing filing based on existing REACH official registration dossiers of domestically produced BDP of the same grade, completing REACH customs clearance filing for this batch of goods within 7 working days as a substitute for monomer registration certificates missing from the manufacturer.
2. Collect samples and send them to authorized third-party laboratories for full screening of the latest ECHA 253-item SVHC list, targeted testing of three easily exceeding substances: free phenol, phthalate plasticizers and heavy metals, finally issuing EU-format English SVHC compliance reports with all test results below the 0.1% control threshold.
3. Entrust EU compliance institutions to complete online SCIP system notifications based on test data and product component lists, generate exclusive SCIP declaration codes, and synchronize filing into the client’s supply chain ledger to meet random inspection requirements of Swiss customs.
1. Conduct total migration and specific substance precipitation testing in accordance with German LFGB (EU 10/2011) food contact regulations, adopting exclusive testing standards for medical materials differentiated from general grades, obtaining English LFGB compliance certificates issued by German-recognized laboratories within 5 working days.
2. Mark the maximum allowable addition dosage of BDP in PC/ABS substrates on certificates, paired with compliance declarations (DoC) directly applicable to incoming warehouse audits of Roche’s medical supply chain.
1. Cooperate with the manufacturer’s technical department to split all BDP components: main active substances, trace residual TPP, synthetic additives and impurity contents, marking CAS numbers, mass ratios and hazardous substance limit values of each component item by item.
2. HiSiaddi compliance specialists organize standardized data sheets in accordance with the latest IMDS 15.3 version specifications, guiding the client’s compliance specialists to complete one-click entry into the European IMDS system and generate exclusive material codes for automotive parts to satisfy Volvo’s full-vehicle material traceability control.
1. Coordinate manufacturers to replace compliant UN dangerous goods packaging and submit to domestic commodity inspection authorities for Class 9 dangerous goods UN packaging use certificates.
2. Remake bilingual Chinese-English outer packaging labels in compliance with the 6th revised GHS edition, marking hazard pictograms, precautionary statements and emergency contact numbers; recompile EU-standard 16-section English MSDS (SDS), submitting to freight forwarders and customs brokers for pre-review synchronously.
3. Cooperate with freight forwarders to adopt a dedicated green channel for chemical dangerous goods, complete maritime declarations and customs pre-reviews, lifting shipping companies’ refusal to accept cargo.
SVHC and LFGB test certificates issued, REACH filing and SCIP notifications fully completed, with full sets of English compliance documents sent to Swiss client legal teams and customs pre-review departments.
Factories completed drum replacement and label re-sticking, UN dangerous goods packaging certificates issued; IMDS data entry finished and approved by Volvo’s backend system.
Full sets of customs, maritime and shipping documents were completed, enabling on-time loading and shipment of the 65-ton first container to the Port of Rotterdam. After goods arrival, EU customs spot-checked compliance documents and cleared the cargo at one time without detention or fines, allowing the client to smoothly receive goods and launch production.
The client conducted small-batch mass production on medical PC/ABS and automotive modification lines respectively, with finished products passing third-party compliance re-inspections by Roche and Volvo, and flame retardant and precipitation indicators matching imported European and American BDP.
1. Annual compliance file custody: HiSiaddi establishes exclusive compliance archives for this grade of BDP. After ECHA updates the SVHC list every year, supplementary testing of newly added items is completed at the first time, and full REACH, SCIP and LFGB documents are updated synchronously. Subsequent four shipments avoid repeated high-cost testing, only requiring batch compliance declarations.
2. Precedent new regulation early warning: Real-time synchronization of the latest chemical policies in the EU, Switzerland and Germany (PFAS control, new automotive material regulations, etc.) to pre-judge compliance risks, coordinating manufacturers to fine-tune raw material processes to avoid restricted substances in advance if regulatory changes occur.
3. Supporting compliance for new products: When the client develops low-precipitation medical modified BDP later, HiSiaddi pre-audits compliance paths in advance to avoid high-concern substances at the formulation source, with new products passing compliance testing at one time and securing an additional annual incremental order of 70 tons.
Domestic BDP manufacturers focus on physical and chemical production of products, generally lacking supporting capabilities for European and American multi-country regulatory compliance, only able to provide domestic quality inspection certificates without familiarity with cross-border compliance systems including REACH/SVHC/LFGB/IMDS. Mid-to-high-end overseas clients operate in markets with strict regulations and lack understanding of China’s chemical registration, testing and dangerous goods declaration processes, facing high risks of customs detention, product scrapping and order breach penalties when purchasing domestic additives. Fragmented rectification by separate third-party compliance institutions leads to long cycles, high costs and extremely low efficiency from multi-party coordination.
Acting as a hub of third-party foreign trade service providers, HiSiaddi integrates full-chain resources including testing, EU OR registration, dangerous goods declaration and regulatory consulting to close multi-country, multi-category compliance challenges in one stop. It addresses both manufacturers’ insufficient compliance capabilities and overseas high-end clients’ risks of customs detention, product scrapping and large order breach compensation losses.
For high-end procurement in European medical and automotive sectors, compliance qualifications carry equal importance to product performance. Complete full-lifecycle compliance supporting services serve as the core competitiveness for domestic BDP to break import monopolies and stabilize large long-term orders, while low unit prices and qualified physical and chemical indicators alone cannot gain access to high-end supply chains.
Please contact HiSiaddi customer service if you need more consultation on compliance issues of bisphenol A bis(diphenyl phosphate) products.
+86-13120989737 
info@hisiaddi.com 
English
